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Abstract 
 
Objective: Retrospective symptom reports are an important source of information in both 
laboratory and clinical settings. The present study investigated memory for experimentally 
induced pain and dyspnea in high and low habitual symptom reporters (HSR).  
Methods: Healthy women (N=48; 24 high/24 low HSR) participated in two laboratory 
studies. One study included two pain episodes (cold pressor task), the other study included 
two dyspnea episodes (rebreathing task). Pain and dyspnea ratings were collected (1) 
continuously during symptom inductions, (2) after each trial, (3) immediately after the 
experiment, and (4) at 2-week follow up. Symptom ratings, negative affect (NA) and anxiety 
measures were also completed following each trial. 
Results: While the retrospective pain ratings were higher in the high compared with the low 
HSR group (p = .01), both groups rated recalled dyspnea higher relative to concurrent 
dyspnea (p < .001). A further increase in bias over time was only found for dyspnea in high 
HSR (p = .02). Moreover, dyspnea induction was associated with higher state NA (p = .03) 
and anxiety (p = .007) than pain induction. 
Conclusions: Our findings show that even though memory for pain and dyspnea is overall 
distorted, the extent of bias in symptom recall clearly differs between symptoms and groups. 
The observed increase of dyspnea reporting over time may have important implications for 
diagnostic assessment based on symptom reporting. 
 
Keywords: pain, dyspnea, symptom memory, biased symptom recall, habitual symptom 
reporting 
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Retrospective descriptions of somatic experiences are important sources of 
information for health care professionals and can influence clinical diagnosis and treatment 
choice. Interestingly, a considerable number of patients in both primary (Barsky, Orav, & 
Bates, 2005; Khan, Khan, Harezlak, Tu, & Kroenke, 2003) and secondary health care 
(Carson et al., 2000; Nimnuan, Rabe-Hesketh, Wessely, & Hotopf, 2001) tend to report 
symptoms in the absence of underlying physical dysfunction (often called Medically 
Unexplained Symptoms; MUS). In the recently proposed DSM-5 (American Psychiatric 
Association, 2013) most of these patients would meet criteria for somatic symptom disorder 
(SSD), which emphasizes the presence of persistent distressing somatic symptoms, as well as 
excessive thoughts, feelings and behaviors linked to those symptoms. Various studies have 
explored the perceptual-cognitive processes underlying symptom overreporting in this group 
(Rief & Broadbent, 2007; Van den Bergh, Bogaerts, & Van Diest, in press), but few studies 
have focused on the role of memory processes herein. 
Although research on memory for symptoms often results in contradictory findings, 
one consistent conclusion is that memory for symptoms is relatively inaccurate and mostly 
results in retrospective overestimation of experienced symptoms (Broderick et al., 2008; 
Giske, Sandvik, & Røe, 2010; Linton & Melin, 1982). Several sources of bias have been 
identified: (1) variability of real-time symptom levels (Lefebvre & Keefe, 2002; Sohl & 
Friedberg, 2008; Stone, Schwartz, Broderick, & Shiffman, 2005), (2) symptom intensity 
(Feine, Lavigne, Thuan Dao, Morin, & Lund, 1998; Giske et al., 2010; Hunter, Philips, & 
Rachman, 1979; Sohl & Friedberg, 2008), (3) emotional state during symptom experience 
(Everts et al., 1999; Gedney & Logan, 2004), (4) symptom intensity during recall (Eich, 
Reeves, Jaeger, & Graff-Radford, 1985; Lefebvre & Keefe, 2002; Meek, Lareau, & 
Anderson, 2001; Smith & Safer, 1993), (5) time since actual symptom episode (Broderick et 
al., 2008; Houtveen & Oei, 2007), and (6) cognitive heuristics, such as the peak-end effect 
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(Kahneman, Fredrickson, Schreiber, & Redelmeier, 1993). The peak-end effect assumes that 
the retrospective evaluation of an experience is predominantly determined by two distinctive 
moments, the one with the highest intensity (peak) and the final (end) part of the episode, 
with relative duration neglect, meaning that the actual duration of the experience has a 
limited influence on the global retrospective evaluation. The influence of this heuristic on 
symptom memory was confirmed not only in the laboratory (Bogaerts et al., 2012; Kahneman 
et al., 1993), but also in naturalistic settings, such as during medical examinations 
(Redelmeier & Kahneman, 1996; Redelmeier, Katz, & Kahneman, 2003) and childbirth 
(Chajut, Caspi, Chen, Hod, & Ariely, 2014). Finally, psychological factors may inflate both 
concurrent (catastrophizing, Lefebvre & Keefe, 2002; Sohl & Friedberg, 2008; anxiety, Suls 
& Howren, 2012) and retrospective (depression, Suls & Howren, 2012) symptom ratings. 
Also negative affectivity (NA) has been found to be strongly related to memory distortions 
for symptoms (Levine & Safer, 2002; Safer, Levine, & Drapalski, 2002). Similarly, trait NA 
is associated with a tendency to attend more to somatic information (Stegen, Van Diest, Van 
de Woestijne, & Van den Bergh, 2001) and to interpret it as threatening (Stegen, Van Diest, 
Van de Woestijne, & Van den Bergh, 2000), as well as to overreport symptoms during recall 
(Larsen, 1992). 
Even though memory processes play an important role in biased symptom reporting, 
only a limited number of studies has explored memory for bodily symptoms among patients 
with MUS or non-consulting high habitual symptom reporters (HSR). Bogaerts et al. (2012) 
investigated the peak-end effect in the memory for dyspnea in patients with medically 
unexplained dyspnea (MUD) and healthy participants. Dyspneic experience was 
experimentally induced with two rebreathing trials: one ended at the peak of dyspnea, while 
in the other a recovery phase was added to assure a milder end. The expected peak-end effect 
was observed among healthy participants, but not in the MUD group. Because the patients 
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displayed a slower recovery in self-reported dyspnea which could not be accounted for by 
differences in respiratory physiology, it is suggested that perceptual-cognitive processing of 
aversive sensations among patients with MUD differs from healthy people. Investigating a 
non-consulting high HSR group, Houtveen and Oei (2007) conducted a diary study and found 
that, compared to averaged concurrent symptom reports, both high and low HSR reported 
experiencing more symptoms during recall. However, only high HSR showed a gradual 
increase in estimation of experienced symptoms with longer time frames. Moreover, biased 
recall in high HSR was not related to the hypothesized sources of bias, i.e. the peak-end 
effect and symptom variability. Taken together, delayed recovery in symptom reports but not 
in physiological dysfunction, as well as bias in retrospective symptom reporting, suggest 
distorted and less detailed perceptual-cognitive processing of symptom experiences in 
persons with MUS. 
In view of this limited set of findings, the present study aimed to advance our 
understanding of the role of perceptual-cognitive biases affecting retrospective symptom 
reports. The primary goals of this study were to investigate whether the retrospective 
symptom reports are subject to recall biases leading to increased symptom reporting and 
whether such biases are larger for high HSR. To this end, retrospective memory for two 
experimentally induced and well-controlled aversive bodily sensations, i.e. pain and dyspnea, 
was examined. We selected participants high and low on HSR and administered the two 
aversive sensations within subject to examine the generality of the findings across symptom 
types. In one study (StudyPain), a painful experience was induced by means of the cold 
pressor task (CPT), while in the other (StudyDyspnea), dyspnea was induced via a 
rebreathing paradigm (Read, 1967). Each study consisted of two trials in order to investigate 
the peak-end effect: One terminated at peak distress, while the other included an additional 
recovery phase to end at a less distressing level. Participants rated their concurrent symptom 
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levels while being exposed to aversive stimuli during the trials, which were followed by three 
retrospective ratings of induced symptoms and affective responses. Based upon the 
arguments described above, the following hypotheses were tested in each study separately: 
(1) Retrospective symptom ratings were expected to be higher than averaged concurrent 
ratings, with this effect being more pronounced in high HSR; (2) Recalled symptom reports 
were expected to increase over time in high HSR, but not in low HSR; (3) According to the 
peak-end rule, short trials were expected to be retrospectively rated as more intense than the 
long trials. However, this effect was hypothesized to be present in low, but not high, HSR 
(Bogaerts et al., 2012; Houtveen & Oei, 2007). Possible differences between the two 
symptom types were investigated in an exploratory manner, thus no specific hypotheses were 
formulated regarding these differences. 
Methods 
Participants 
Forty-eight healthy students (all women), aged 18 – 27 years, participated in both 
experiments in return for two course credits or 15 euros. They were selected after screening 
for habitual symptom reporting via the Checklist for Symptoms in Daily Life (CDS; Wientjes 
& Grossman, 1994). Predefined cut-off scores were used to select high (≥ 100; n = 24) and 
low (≤ 75; n = 24) habitual symptom reporters (HSR). Cut-off scores were based on upper 
and lower quartiles of the scores on this questionnaire found in large samples from the same 
population (Bogaerts et al., 2008). Prior to the experiment, participants completed the CDS a 
second time; only participants who still met the cut-offs were included. 
Exclusion criteria were any self-reported chronic illness (e.g. pulmonary, 
cardiovascular, gastrointestinal, neuromuscular diseases), acute illnesses, fever or headache, 
major psychiatric condition, diabetes, recent arm fracture or wrist sprain prior to 
participating, earlier frostbite, and pregnancy. The experimental protocol was approved by 
6 
 
RETROSPECTIVE MEMORY IN SYMPTOM REPORTING 
 
the Multidisciplinary Ethical Committee of the Faculty of Psychology and Educational 
Sciences of the University of Leuven. 
Measures 
Habitual symptom reporting. Habitual symptom reporting was assessed using the 
adapted version of The Checklist for Symptoms in Daily Life (CDS; Wientjes & Grossman, 
1994). Participants rated how often they experienced 39 listed symptoms in the past year on a 
5-point Likert scale (never, seldom, sometimes, often, very often). The total score (range: 39 – 
195) was used to select high/low HSR; reliability (Cronbach’s α) exceeded .95 in our sample. 
Negative affectivity. Trait and state Negative Affectivity (NA) were assessed with the 
Dutch version of the Positive and Negative Affect Schedule. The PANAS consists of 20 
positive and negative adjectives for which participants had to indicate (on a 5-point Likert 
scale ranging from not at all to very much) to which extent they felt that way in general (trait) 
or now (state). Good reliability and validity have been reported (Engelen, De Peuter, Victoir, 
Van Diest, & Van den Bergh, 2006; Watson, Clark, & Tellegen, 1988). 
State symptom checklist. At baseline and after every symptom induction trial in both 
studies, a state symptom checklist was administered. Participants had to rate to which extent 
they experienced each of 12 symptoms now (baseline) or during the past trial on a 5-point 
rating scale ranging from 0 (not at all) to 4 (very much). This symptom list included: chest 
tightness, pounding of the heart, stomach or abdominal cramps, headache, fatigue, not able 
to breathe deeply, rapid heartbeat, nausea, dizziness, muscular pain, dyspnea, pain. State 
symptom checklists showed acceptable and good internal consistency, with Cronbach’s 
alphas ranging from .70 to .86. 
State anxiety and threat. A numerical rating scale (NRS) was used to evaluate the 
level of anxiety (1 = not anxious at all, 9 = very anxious) at the baseline and after every 
symptom induction trial in both studies. Additionally, after every symptom induction trial, a 
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NRS concerning the threat value of each trial (1 = not threatening at all, 9 = very 
threatening) was administered. 
Concurrent symptom ratings. During each symptom induction trial, concurrent 
symptom ratings were collected on a 0-100 computerized scale. The scale was presented as a 
vertical bar in the middle of the screen. Different levels of the experienced pain/dyspnea, 
based on a modified Borg scale (Borg, 1982), were verbally described on its right side: none 
(0), very slight (10), slight (20), moderate (30), fairly severe (40), severe (50), very severe 
(60), very severe (70), very severe (80), very, very severe (90), intolerable (100). In 
StudyPain, perceived pain was rated continuously with a scroll wheel (sampling every 
second), while in StudyDyspnea perceived dyspnea was rated every 10s (after auditory cue) 
with a mouse click. 
Retrospective symptom ratings. In both studies, the retrospective evaluations of 
symptoms experienced during each trial were collected at three moments: immediately after 
each trial (immediate rating), at the end of the experimental session (delayed rating) and in a 
two weeks follow-up (follow-up rating). Participants indicated the average symptom level 
(StudyPain: pain/ StudyDyspnea: dyspnea) experienced during the trial (How much pain/ 
dyspnea have you experienced on average during this trial?) on a visual analog scale (10cm) 
ranging from 0 (no pain/ dyspnea) to 100 (maximum pain/ dyspnea). The follow-up ratings 
for both studies were collected on a single occasion two weeks after the last study. 
Apparatuses and Physiological Recordings 
StudyPain: Pain induction – the cold pressor task (CPT). During the two trials of 
the cold pressor task (CPT), participants immersed their hand in a Plexiglas box (Julabo®) 
filled with 18L of water. The water temperature was controlled by an electric immersion 
cooler, type FT200, and a bath circulator, type ED-19A. This ensured that the temperature 
could be either maintained at a constant level (12°C) or increased by 2°C in 60s. The changes 
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in water circulation during temperature manipulation were unnoticeable for the participant. In 
contrast with Kahneman et al. (1993), who used 14°C to induce pain and 15°C to induce 
discomfort reduction, temperatures in the current experiment were set at 12°C and 14°C (± 
0.3°C), after a pilot study showing a detectable change in discomfort with these temperatures, 
which was not observed with 14°C and 15°C. The Plexiglas box was placed upon a trolley 
adjustable in height to provide comfortable access. Before each CPT, participants were asked 
to hold both hands in the second box (type FT200 Julabo®), in which water was kept at room 
temperature (20.5°C ± 0.3°C). A 2-minute baseline was used to ensure that the skin 
temperature of the participants was similar before each trial. 
StudyDyspnea: Dyspnea induction – the rebreathing paradigm. Two trials of the 
standardized rebreathing paradigm (Read, 1967, see also Bogaerts et al., 2012) were used to 
induce the sensations of dyspnea. During the trials, participants wore a nose clip and breathed 
through a mouthpiece, connected to the rebreathing bag via a wide vinyl tube and a Y-valve 
ending on a pneumotachograph (Fleisch no. 2, Lausanne, Switzerland) measuring airflow. 
The valve allowed to switch between room air and the rebreathing bag, which was initially 
filled with 5-liter gas mixture of 5% CO2 and 95% O2. Breathing in this closed hyperoxic 
system led to a progressive rise of PCO2, of minute ventilation and of dyspnea, defined as 
uncomfortable feeling of not having enough air, an urge to breathe, or a feeling of having 
more difficulty in breathing. Fractional end-tidal concentration of CO2 (FetCO2) was 
determined using an infrared CO2 monitor (POET RC, Criticare Systems Inc., Waukesha, 
WI). The exhaled air was sampled close to the mouthpiece. The data from the 
pneumotachograph and the CO2 monitor were sampled at 20Hz and stored on a computer. All 
data were stored and analyzed offline to determine the following parameters: minute 
ventilation (MV) in L/min and FetCO2 in %. The manipulation of the valve was undetectable 
9 
 
RETROSPECTIVE MEMORY IN SYMPTOM REPORTING 
 
by the participants to make sure that they depended exclusively on the experienced bodily 
changes to give their concurrent ratings. 
Procedure 
Selected participants were invited to participate in two experiments examining the 
relationship between bodily sensations and well-being. One day before the laboratory 
sessions, participants completed the trait questionnaires (CSD, PANAS) online. Upon arrival 
in the laboratory, participants signed the informed consent, were informed about the 
procedure and completed the questionnaires (state symptoms checklist, PANAS and anxiety). 
Participants completed both studies on two consecutive days and the order of the studies and 
the trials within study was counterbalanced across participants. 
In StudyPain, two CPT trials were administered, one on each hand, with a 7-minute 
intertrial interval. Each trial began with a baseline period, during which participants 
immersed both hands in room-temperature water. For the short trial, baseline was followed 
by a cold phase (60 seconds in 12°C water) after which participants could withdraw their 
hand. For the long trial, baseline was followed by the same cold phase (60 seconds in 12°C) 
with an additional recovery phase (60 seconds) during which the temperature increased to 
14°C (unknown to the participants). The order of trials (short/long, to the 
dominant/nondominant hand) was counterbalanced across participants. 
In StudyDyspnea, participants went through two rebreathing trials, the order of which 
was counterbalanced across participants. A short trial consisted of a baseline (60 seconds of 
room-air breathing) and a rebreathing phase (150 seconds). After 150-second rebreathing, the 
trial was stopped and participants could breathe freely outside of the rebreathing system. In a 
long trial, the baseline (60 seconds) and rebreathing phases (150 seconds) were followed by 
an additional recovery phase (150 seconds), initiated by unobtrusively switching the valve to 
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room air. Full recovery between the trials was ensured by a 15-minute intertrial interval. 
Respiration was measured throughout each trial. 
Average pain/dyspnea experienced during the trials was rated after each trial 
(immediate rating), followed by the ratings of state affect, symptoms and anxiety. After two 
trials of each study, the average pain/dyspnea ratings were repeated (delayed rating). Two 
weeks after the second session participants completed an online questionnaire regarding 
retrospective ratings for both trials in each of the studies (follow-up rating). 
Data Analyses 
Manipulation check: Concurrent symptom ratings. Concurrent symptom ratings 
were analyzed to verify the effect of symptom induction and to examine whether symptom 
reports differed between high and low HSR. Concurrent ratings were divided into equal time 
segments of 10 seconds (StudyPain) or 30 seconds (StudyDyspnea) in order to acquire a 
detailed picture of the somatic experience. Separate repeated-measures analyses of variance 
(ANOVAs) were conducted on self-reported symptom ratings (pain/dyspnea) during each 
trial as dependent variables, with Group and Order of trials as between-subject factors and 
Time segment as within-subject variable. Moreover, the effect of dyspnea induction on 
respiratory behavior was investigated by separate repeated measures ANOVAs on MV and 
FetCO2 (per 30 seconds) during each trial as dependent variables, with Group and Order of 
trials as between-subject factors and Time segment as within-subject variable. 
Testing hypotheses: Retrospective symptom ratings. To assess symptom memory 
in both studies, separate repeated measures ANOVAs were performed on symptom ratings 
(pain/dyspnea) as dependent variables, with Group (high/low HSR) and Order of trials as 
between-subjects factors, Trial (short trial/long trial) and Moment of symptom assessment 
(averaged concurrent/immediate/delayed/follow-up) as within-subject factors. The averaged 
concurrent symptom scores were averaged across the actual symptom reports given during 
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pain and dyspnea inductions per trial. Planned contrasts were used to examine specific time 
and group effects (C1: averaged concurrent vs. all retrospective ratings to test Hypothesis 1; 
C2: retrospective ratings during experimental session (immediate, delayed) vs. follow-up 
ratings to test Hypothesis 2), as well as trial effects (C3: averaged concurrent vs. immediate 
ratings to test Hypothesis 3). Greenhouse–Geisser corrections were applied when the 
sphericity assumption was violated. 
Affective responses. In order to investigate the differences in affective responses to 
different bodily stimuli, data regarding affective states during both studies were analyzed 
together. Repeated measures ANOVAs were carried out on state symptom, NA and anxiety 
ratings as dependent variables, with Induction (StudyPain/StudyDyspnea) and Moment of 
measurement (baseline/short trial/long trial) as within-subject factors and Group (high/low 
HSR) and Order of studies as between-subject factors. Another repeated measures ANOVA 
was conducted on threat value as dependent variable, with Induction 
(StudyPain/StudyDyspnea) and Moment of measurement (short/long trial) as within-subject 
factors and Group (high/low HSR) and Order of studies as between-subject factors. All 
analyses were conducted with SPSS 22.0. 
Results 
Sample characteristics 
Low HSR reported less habitual symptoms than high HSR (low: M = 57.13, SE = 
2.06; high: M = 114.75, SE = 2.61; t(46) = -17.33, p < .001). High HSR also reported higher 
trait NA levels than low HSR, t(38.04) = -7.34, p < .001. 
StudyPain 
Manipulation check: Concurrent pain ratings. No significant group-related 
differences were observed for either pain ratings or their change over time during the short 
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trial, while during the long trial high HSR tended to report more pain, F(1, 44) = 2.98, 
p = .09, 𝜂𝑝2 = .06 (see Fig. 1). 
Testing hypotheses: Retrospective pain ratings. Hypothesis 1 (retrospective 
symptom reporting): Main effects showed that high HSR reported overall more pain than low 
HSR, F(1, 44) = 4.80, p = .03, 𝜂𝑝2 = .10 (Fig. 2, left panel) and that pain was higher when 
rated retrospectively than concurrently, C1: F(1, 44) = 58.99, p < .001, 𝜂𝑝2 = .57. Moreover, 
the latter effect was stronger in high HSR than in low HSR participants, C1 for Group × 
Moment: F(1, 44) = 6.63, p = .01, 𝜂𝑝2 = .13; Group × Moment: F(2.43, 106.96) = 3.53, 
p = .03, 𝜂𝑝2 = .07. Hypothesis 2 (increase in retrospective symptom reporting over time): 
Retrospective ratings did not further increase over time, C2: F(1, 44) = 1.35, p = .25, 
𝜂𝑝
2 = .03. Hypothesis 3 (peak-end effect): Even though the concurrently rated pain was lower 
in the short trial than in the long trial, pain rating in the immediate rating was higher for the 
short, compared with the long, trial, C3: F(1, 44) = 17.38, p < .001, 𝜂𝑝2 = .28 (Fig. 3, left 
panel); Trial × Moment: F(1.91, 83.99) = 4.69, p = .01, 𝜂𝑝2 = .10. This confirmed the peak-
end effect, but no group differences appeared for this interaction, C3: F(1, 44) = 1.22, 
p = .28, 𝜂𝑝2 = .03; Trial × Group × Moment: F(1.91, 83.99) = .75, p = .47, 𝜂𝑝2 = .02.  
StudyDyspnea 
Manipulation check: Concurrent dyspnea ratings. Group-related differences were 
observed for concurrent symptom ratings in both trials, with high HSR reporting more 
dyspnea during the short, F(1, 41) = 9.53, p < .01, 𝜂𝑝2 = .19, and the long trial, F(1, 
41) = 3.97, p = .05, 𝜂𝑝2 = .09 (Fig. 4). Moreover, this difference became stronger over time 
during the short trial (Group × Time segment: F(1.50, 61.40) = 5.81, p < .01, 𝜂𝑝2 = .12). No 
group differences were observed for either FetCO2 or MV during the rebreathing trials. 
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Testing hypotheses: Retrospective dyspnea ratings. Hypothesis 1 (retrospective 
symptom reporting): Retrospective dyspnea ratings were higher compared to averaged 
concurrent ones, C1: F(1, 43) = 126.63, p < .001, 𝜂𝑝2 = .75 (Fig. 2, right panel); Moment of 
symptom assessment: F(2.29, 98.55) = 64.45, p < .001, 𝜂𝑝2 = .60. However, the expected 
group differences were not found for dyspnea ratings, F(1, 43) = 1.70, p = .20, 𝜂𝑝2 = .04. 
Hypothesis 2 (increase in retrospective symptom reporting over time): A Group × Moment of 
symptom assessment interaction emerged, F(2.29, 98.55) = 3.02, p = .05, 𝜂𝑝2 = .07, revealing 
that high HSR gave higher follow-up ratings compared to immediate and delayed ratings than 
low HSR (C2: F(1, 43) = 6.39, p = .02, 𝜂𝑝2 = .13). Hypothesis 3 (peak-end effect): Even 
though the concurrently rated dyspnea did not differ between the trials, dyspnea in the 
immediate rating was higher for the short, compared with the long, trial, C3: F(1, 43) = 
28.09, p < .001, 𝜂𝑝2 = .40 (Fig. 3, right panel); Trial × Moment: F(2.09, 89.90) = 10.37, 
p < .001, 𝜂𝑝2 = .19. This confirmed the peak-end effect, but no group differences appeared for 
this interaction, C3: F(1, 43) = .81, p = .37, 𝜂𝑝2 = .02; Trial × Group × Moment: F(2.09, 
89.90) = .40, p = .68, 𝜂𝑝2 = .01.1 
1 The effect of the order of studies was additionally investigated by including Order of studies as a between-
subject factor to the repeated measures ANOVAs reported above. The abovementioned effects did not change. 
A small tendency towards sensitization was observed for the concurrent and retrospective pain ratings, when the 
pain induction was preceded by the dyspnea induction (concurrent pain ratings: Time segment × Order of 
studies in short trial, F(1.62, 64.77) = 3.59, p = .04, 𝜂𝑝2 = .08, and in long trial, F(2.45, 97.87) = 4.60, p = .01, 𝜂𝑝2 
= .10; retrospective pain ratings: Order of studies, F(1, 40) = 4.00, p = .05, 𝜂𝑝2 = .09). A tendency towards 
habituation was found for concurrent ratings of dyspnea in the short trial (Time segment × Order of studies, F(1, 
37) = 3.94, p = .06, 𝜂𝑝2 = .10). However, no interactions between the order of studies and the group variable 
emerged. 
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Affective responses 
High HSR had higher state NA than low HSR, F(1, 44) = 9.71, p < .01, 𝜂𝑝2 = .18. The 
dyspnea induction resulted in higher state NA after the trials than the pain induction 
(Induction × Moment: F(2, 88) = 3.80, p = .03, 𝜂𝑝2 = .08). State symptom and anxiety ratings 
followed a similar pattern, as can be seen in Table 1. No group differences regarding the 
threat value of the trials were observed. However, the short rebreathing trial was overall more 
threatening than the long trial, while the threat value of pain induction trials did not differ 
(Induction × Moment: F(1, 44) = 5.18, p = .03, 𝜂𝑝2 = .11). Moreover, mediation analyses (see 
Supplementary Online Material) showed that for three out of four trials (except for short pain 
trial) state NA during the trial was a significant mediator of the association between the 
habitual symptom reporting and retrospective symptom ratings. 
Discussion 
The present study aimed to investigate the course of retrospective memory for two 
distinct aversive bodily sensations, i.e. pain and dyspnea, across a 2-week period and whether 
individual differences in habitual symptom reporting would moderate this course over time. 
These sensations were experimentally induced in the laboratory to individuals scoring high or 
low on habitual symptom reporting (HSR). Concurrent symptom ratings collected during the 
inductions served as a reference point for comparisons with retrospective ratings collected at 
three fixed time points after the symptom induction. Consistent with previous research, it was 
found that retrospective memory for symptoms is inaccurate and that the course of bias over 
time differs between the groups. In addition, differences between the two aversive bodily 
sensations were also observed. 
The manipulation checks indicated a successful pain and dyspnea induction. 
Nonetheless, it was also found that the groups differed in their concurrent symptom 
perception, with high HSR reporting more symptoms than low HSR, especially during 
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dyspnea induction. However, physiological responses to this induction, as measured by MV 
and FetCO2, were not different. These observations are in line with the findings of Bogaerts 
et al. (2010) who showed increased concurrent dyspnea ratings in MUD patients compared to 
healthy controls, despite the lack of differences at the physiological level.  
Considering retrospective symptom ratings, two important findings emerged: (1) 
symptoms are retrospectively biased, and (2) the pattern of bias in symptom recall differs 
between low and high HSR. With regards to the first finding, retrospective ratings for both 
pain and dyspnea were overall higher than averaged concurrent evaluations. This accords 
with previous research on the inaccuracy of symptom memory in general, showing that the 
overall retrospective evaluation of the experience is usually more aversive than the averaged 
concurrent reports (e.g. Broderick et al., 2008; Giske et al., 2010; Houtveen & Oei, 2007). It 
should be noted, however, that previous studies investigating this discrepancy were mostly 
based on diary protocols and included longer time frames (starting from one day 
recollections). To our knowledge, our study is the first to show that the global evaluation is 
biased already immediately after the symptom episode. This discrepancy is often explained 
by peak/saliency effects (Kahneman et al., 1993; Miron-Shatz, Stone, & Kahneman, 2009; 
Stone et al., 2005) which suggests that the peak intensity of the experience, due to its aversive 
and threat-signaling connotation, is more heavily weighted during retrospective assessment of 
averaged symptoms while other symptom-free moments tend to be disregarded. Findings 
related to trial differences support this idea: during immediate ratings, the short trials (ending 
at aversive peak) were consistently rated as more intense than the long trials, including 
gradual recovery. Interestingly, this difference was found not only when the averaged 
concurrent ratings of both trials did not differ (dyspnea induction), but also when the long 
trial caused more concurrent pain than the short one. However, in contrast to earlier findings 
showing a lack of the peak-end heuristic in high symptom reporters (patients: Bogaerts et al., 
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2012; non-clinical HSR: Houtveen & Oei, 2007), no group differences emerged for the peak-
end related findings. While this may be due to methodological differences (diary vs. 
experimental study, peak-end effect measured by forced-choice preferences for the short or 
long trial vs. by actual symptom ratings), it could also suggest that this heuristic is used to the 
same extent by both groups. Further work is needed to elucidate this issue. 
Secondly, the pattern of bias in retrospective symptom reporting differed between the 
groups. In pain induction, group differences emerged for immediate evaluations in that high 
HSR reported having experienced more pain than low HSR, while in dyspnea induction both 
high and low HSR reported similar levels of dyspnea. This pattern of results could be caused 
by the differences in symptom intensity and affective reactions to symptom manipulations. In 
the current study, pain induction was associated with less state symptoms, and lower state NA 
and anxiety levels than dyspnea induction. We assume that the lower intensity and threat 
value of pain induction allowed for the increased influence of the trait characteristics, such as 
habitual symptom reporting or NA. This interpretation is in line with previous findings 
showing that trait NA and HSR influence somatic complaints especially when symptoms are 
ambiguous or low in intensity (Bogaerts et al., 2008; De Peuter et al., 2007; Larsen, 1992; 
Stegen et al., 1998, 2001; Van Diest et al., 2005). 
The differences were also observed for the pattern of retrospective symptom reporting 
over time: while there was no increase in recalled pain over the course of two weeks, dyspnea 
reports increased over time in high HSR, but not in low HSR group. This corroborates the 
findings from the diary study by Houtveen and Oei (2007), who observed a rise in 
retrospective symptoms reporting over time in high HSR participants, but it is currently 
unclear why increasing bias in symptom recall over time in the high HSR group was specific 
for dyspnea. One reason could be related to the ratio of sensory and affective processing of 
bodily information used during retrospective recall. Sensory and affective aspects of somatic 
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information are processed in parallel (Leventhal, Brown, Shacham, & Engquist, 1979), but a 
focus on one component may decrease attention to the other. In contrast to sensory 
processing of bodily signals, which leads to more detailed perception and reduced symptom 
ratings (Cioffi, 1991; Crane & Martin, 2003), affective processing of usually unpleasant and 
aversive symptom experience may lead to negative affect biasing both symptom perception 
and retrospective memory (Bogaerts et al., 2008; Michael & Burns, 2004). It is plausible that 
high HSR, who also have elevated NA, focus relatively more on the affective aspects of the 
somatic experience, reducing the influence of the actual sensory input. This way, the level of 
NA and anxiety experienced during symptom induction could affectively color the memory 
of experience, resulting in reporting bias. This explanation is to some extent supported by the 
findings from the mediation analyses, which showed that the relationship between the 
habitual symptom reporting and retrospective symptom ratings was mediated by the state 
NA. Moreover, because the pain induction was not as distressing as the dyspnea induction, 
the negative biasing of the affective component might have been attenuated in this condition. 
Further research is needed to explore the processing styles adopted by high HSR and their 
possible influence on symptom memory bias in equally distressing somatic conditions. 
The findings from this study make several contributions to the current literature. First, 
as one of the first studies it has investigated memory for symptoms in high habitual symptom 
reporters by means of experimentally controlled symptom inductions. The inclusion of both 
concurrent symptom ratings and physiological responses during controlled symptom 
inductions together with retrospective evaluations of the same experience extend our 
knowledge of symptom perception and memory, without being undermined by possible 
physiological differences. Second, symptom memory was found to be substantially biased 
already immediately after the end of experience, with relatively little change thereafter. This 
is important for studies assessing the accuracy of symptom memory with methods such as the 
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Ecological Momentary Assessment (EMA, Shiffman, Stone, & Hufford, 2008) or the 
Experience Sampling Method (ESM, Larson & Csikszentmihalyi, 1983). In the majority of 
studies using EMA or ESM, such immediate ratings would be considered concurrent and 
relatively unbiased, while our data show that, by then, biases have had most of their effect 
already. Finally, by investigating two types of symptoms, i.e. pain and dyspnea, in two 
different groups, our findings point to the role of particular characteristics of the aversive 
bodily sensations that, in interaction with individual differences, determine retrospective 
memory for symptoms. 
The present study has some limitations. First, the current study used a healthy female 
HSR sample, which may limit the generalizability of the findings to a clinical MUS 
population. However, given that our findings concerning dyspnea perception were largely in 
line with the previous study using the rebreathing paradigm in patients with MUD (Bogaerts 
et al., 2012), it could be expected that other cognitive processes (i.e. memory) are comparable 
in those two groups. Second, different concurrent assessment procedures (continuous vs. 
every 10 seconds) were applied in both studies. Nonetheless, because the participants were 
inquired to rate an average symptom experience, the influence of the trial duration and 
frequency of assessment should not have a great impact on the ratings.  
In conclusion, the present study documents retrospective memory inaccuracy for 
symptoms, it replicates the peak-end bias in two different bodily sensations, and it extends 
our understanding of symptom memory in habitual symptom reporting. The observed 
increase of retrospective dyspnea reporting over time in high HSR corroborates the role of 
perceptual-cognitive and memory processes underlying HSR and MUS. Future research is 
needed to more narrowly specify the precise mechanisms underlying the observed symptom 
memory distortions in high HSR. 
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Figure 1. Mean values and standard errors of concurrent pain ratings (0-100) for high and low 
habitual symptom reporters (HSR) during the short (left) and the long trial (right). 
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Figure 2. Mean averaged concurrent and retrospective pain ratings (0-100, left) and dyspnea 
ratings (0-100, right) for high and low habitual symptom reporters (HSR). Whiskers denote 
standard errors. 
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Figure 3. Mean averaged concurrent and immediate pain ratings (left) and dyspnea ratings 
(right) for short and long trial. Whiskers denote standard errors. 
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Figure 4. Mean values and standard errors of concurrent dyspnea (0-100), mean fractional 
end-tidal concentration of CO2 (FetCO2) and minute ventilation for high and low habitual 
symptom reporters (HSR) in baseline, rebreathing and recovery phase for the short (left) and 
the long trial (right). 
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Table 1. Means and SDs for state symptoms, state NA, state anxiety and threat value, and 
significant effects of Repeated Measures ANOVA for all dependent variables. 
Measure Group StudyPain StudyDyspnea Significant effects 
(F;df) 
  
 
Baseline Short trial Long trial Baseline Short trial Long trial 
State 
symptoms 
low HSR    IND*** (78.39; 1) 
MOM*** 
(27.87; 1.59) 
INDxMOM*** 
(41.74; 1.53) 
HSR*** (35.91; 1) 
M 1.38 2.67 2.75 1.67 8.50 8.08 
SD 1.31 2.08 2.17 1.43 4.94 4.93 
high HSR    
M 7.25 6.83 6.54 7.42 15.13 13.21 
SD 5.24 5.24 3.99 4.68 6.02 6.46 
State NA 
low HSR    IND*** (20.49; 1) 
MOM*** 
(15.70; 2) 
INDxMOM* 
(3.80; 2) 
HSR** (9.71; 1) 
M 12.38 13.17 13.17 13.33 15.00 14.79 
SD 2.53 3.13 3.47 3.07 4.60 3.62 
high HSR    
M 15.21 16.96 16.71 16.13 20.21 19.50 
SD 5.35 6.04 5.69 5.17 6.78 6.54 
State 
anxiety 
low HSR    IND*** (18.87; 1) 
MOM*** 
(50.72; 2) 
MOMxOrder* 
(3.78; 2) 
INDxMOM** 
(5.67; 1.77) 
HSR* (7.30; 1) 
M 1.67 2.58 2.58 2.04 3.79 3.71 
SD 0.82 1.67 1.79 1.23 1.96 1.99 
high HSR    
M 2.58 3.71 4.04 2.88 5.25 4.67 
SD 1.50 2.20 2.22 1.94 2.13 2.16 
Threat 
value 
low HSR        IND* (6.50; 1) 
MOM** (7.40; 1) 
INDxMOM* 
(5.18; 1) 
Order* 
(7.06; 1) 
M  3.54 3.17  4.96 4.25 
SD  2.25 2.04  1.88 2.09 
high HSR    
M  4.54 4.54  5.42 4.50 
SD   2.59 2.50  2.17 2.47 
Note: HSR = Habitual symptom reporting; IND = Induction; MOM = Moment of measurement. 
*p<.05, **p<.01, ***p<.001.  
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